Solara Active Pharma Sciences Ltd.
•₹ 616.9-3.61%
2026-08-21
PROS
- Promoters have been increasing their shareholding - up 4.7pp over 2 years
- Latest quarter profit grew 61.3% YoY, showing strong momentum
- Operating margins have improved to 15.9% from 7.8%
- Company generates healthy free cash flow
CONS
- Company is loss-making at the operating / net level
- Recent results are weak - TTM profit is down 105.5% versus prior year
- Company has a low return on equity of -16.0% over last 3 years
- Company has a low return on capital employed of -3.2%
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.81x)
- Interest coverage is weak at 1.0x - earnings barely cover interest
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | SOLARA | 549.90 | 0.00 | 2653.30 | 0.00 | 163.10 | 1450.38 | 3816.00 | 1095.68 | 6.07 | 16.24 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 352 | 425 | 212 | 299 | 363 | 347 | 300 | 273 | 319 | 314 | 349 | 387 | 382 | |
| 333 | 388 | 374 | 290 | 321 | 286 | 243 | 230 | 262 | 279 | 312 | 330 | 367 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 2 | 1 | 0 | 2 | 1 | 0 | 1 | 6 | 1 | 0 | 0 | 4 | 2 |
| Interest | 26 | 24 | 25 | 31 | 31 | 28 | 27 | 29 | 24 | 21 | 22 | 27 | 20 |
| Depreciation | 26 | 26 | 26 | 25 | 25 | 25 | 25 | 24 | 24 | 24 | 26 | 26 | 27 |
| -30 | -15 | -275 | -168 | -12 | 8 | 8 | -5 | 11 | -10 | -17 | 10 | 17 | |
| Tax % | 34.02% | -0.00% | -0.00% | -52.97% | -0.00% | 0.00% | 0.00% | -0.00% | 0.00% | -0.00% | -0.00% | 0.00% | 0.00% |
| Net Profit | -20 | -15 | -275 | -256 | -12 | 8 | 8 | -5 | 11 | -10 | -17 | 10 | 17 |
| -5 | -4 | -72 | -67 | -3 | 2 | 2 | -2 | 2 | -2 | -4 | 2 | 0 | |
| Equity Capital | 36 | 36 | 36 | 36 | 40 | 40 | 40 | 40 | 44 | 44 | 44 | 45 | 48 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 36 | 36 | 36 | 36 | 40 | 40 | 40 | 40 | 44 | 44 | 44 | 45 | 48 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 352
- 333
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 26
- Depreciation
- 26
- -30
- Tax %
- 34.02%
- Net Profit
- -20
- -5
- Equity Capital
- 36
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 36
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 425
- 388
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 24
- Depreciation
- 26
- -15
- Tax %
- -0.00%
- Net Profit
- -15
- -4
- Equity Capital
- 36
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 36
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 212
- 374
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 25
- Depreciation
- 26
- -275
- Tax %
- -0.00%
- Net Profit
- -275
- -72
- Equity Capital
- 36
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 36
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 299
- 290
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 31
- Depreciation
- 25
- -168
- Tax %
- -52.97%
- Net Profit
- -256
- -67
- Equity Capital
- 36
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 36
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 363
- 321
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 31
- Depreciation
- 25
- -12
- Tax %
- -0.00%
- Net Profit
- -12
- -3
- Equity Capital
- 40
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 40
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 347
- 286
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 28
- Depreciation
- 25
- 8
- Tax %
- 0.00%
- Net Profit
- 8
- 2
- Equity Capital
- 40
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 40
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 300
- 243
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 27
- Depreciation
- 25
- 8
- Tax %
- 0.00%
- Net Profit
- 8
- 2
- Equity Capital
- 40
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 40
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 273
- 230
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 29
- Depreciation
- 24
- -5
- Tax %
- -0.00%
- Net Profit
- -5
- -2
- Equity Capital
- 40
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 40
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 319
- 262
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 24
- Depreciation
- 24
- 11
- Tax %
- 0.00%
- Net Profit
- 11
- 2
- Equity Capital
- 44
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 44
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 314
- 279
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 21
- Depreciation
- 24
- -10
- Tax %
- -0.00%
- Net Profit
- -10
- -2
- Equity Capital
- 44
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 44
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 349
- 312
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 22
- Depreciation
- 26
- -17
- Tax %
- -0.00%
- Net Profit
- -17
- -4
- Equity Capital
- 44
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 44
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 387
- 330
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 27
- Depreciation
- 26
- 10
- Tax %
- 0.00%
- Net Profit
- 10
- 2
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 382
- 367
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 20
- Depreciation
- 27
- 17
- Tax %
- 0.00%
- Net Profit
- 17
- 0
- Equity Capital
- 48
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 48
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| 521 | 1,387 | 1,322 | 1,617 | 1,268 | 1,444 | 1,289 | 1,284 | 1,431 | |
| 457 | 1,165 | 1,065 | 1,232 | 1,188 | 1,310 | 1,384 | 1,080 | 1,287 | |
| Operating Profit | 67 | 234 | 284 | 414 | 99 | 156 | -90 | 213 | — |
| OPM % | 13 | 17 | 21 | 26 | 8 | 11 | -7 | 17 | — |
| Other Income | 2 | 12 | 28 | 28 | 19 | 22 | 5 | 9 | 7 |
| Interest | 25 | 82 | 78 | 84 | 75 | 90 | 106 | 115 | 91 |
| Depreciation | 34 | 83 | 94 | 108 | 112 | 111 | 103 | 99 | 103 |
| 8 | 68 | 112 | 221 | -92 | -45 | -488 | -1 | -1 | |
| Tax % | 0 | 3 | 0 | 0 | 36 | 50 | -16 | 0 | 0 |
| Net Profit | 8 | 66 | 112 | 221 | -59 | -22 | -567 | -1 | -1 |
| EPS | 2 | 21 | 42 | 64 | -16 | -6 | -157 | -0 | — |
| Dividend Payout % | 0 | 19 | 5 | 11 | 0 | 0 | 0 | 0 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 3 | 24 | 39 | 57 | -15 | -6 | -145 | -0 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 3 | 24 | 39 | 57 | -15 | -6 | -145 | -0 | — |
Mar 2018
- 521
- 457
- Operating Profit
- 67
- OPM %
- 13
- Other Income
- 2
- Interest
- 25
- Depreciation
- 34
- 8
- Tax %
- 0
- Net Profit
- 8
- EPS
- 2
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2019
- 1,387
- 1,165
- Operating Profit
- 234
- OPM %
- 17
- Other Income
- 12
- Interest
- 82
- Depreciation
- 83
- 68
- Tax %
- 3
- Net Profit
- 66
- EPS
- 21
- Dividend Payout %
- 19
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 24
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 24
Mar 2020
- 1,322
- 1,065
- Operating Profit
- 284
- OPM %
- 21
- Other Income
- 28
- Interest
- 78
- Depreciation
- 94
- 112
- Tax %
- 0
- Net Profit
- 112
- EPS
- 42
- Dividend Payout %
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 39
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 39
Mar 2021
- 1,617
- 1,232
- Operating Profit
- 414
- OPM %
- 26
- Other Income
- 28
- Interest
- 84
- Depreciation
- 108
- 221
- Tax %
- 0
- Net Profit
- 221
- EPS
- 64
- Dividend Payout %
- 11
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 57
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 57
Mar 2022
- 1,268
- 1,188
- Operating Profit
- 99
- OPM %
- 8
- Other Income
- 19
- Interest
- 75
- Depreciation
- 112
- -92
- Tax %
- 36
- Net Profit
- -59
- EPS
- -16
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -15
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -15
Mar 2023
- 1,444
- 1,310
- Operating Profit
- 156
- OPM %
- 11
- Other Income
- 22
- Interest
- 90
- Depreciation
- 111
- -45
- Tax %
- 50
- Net Profit
- -22
- EPS
- -6
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -6
Mar 2024
- 1,289
- 1,384
- Operating Profit
- -90
- OPM %
- -7
- Other Income
- 5
- Interest
- 106
- Depreciation
- 103
- -488
- Tax %
- -16
- Net Profit
- -567
- EPS
- -157
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -145
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -145
Mar 2025
- 1,284
- 1,080
- Operating Profit
- 213
- OPM %
- 17
- Other Income
- 9
- Interest
- 115
- Depreciation
- 99
- -1
- Tax %
- 0
- Net Profit
- -1
- EPS
- -0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -0
TTM
- 1,431
- 1,287
- Operating Profit
- —
- OPM %
- —
- Other Income
- 7
- Interest
- 91
- Depreciation
- 103
- -1
- Tax %
- 0
- Net Profit
- -1
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- -1%
- 3 Years:
- 0%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- -16%
- 3 Years:
- 25%
- 1 Year:
- 2%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- -7%
- 3 Years:
- -16%
- Last Year:
- 0%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - |
| Equity Capital | 25 | 26 | 27 | 36 | 36 | 36 | 36 | 40 |
| 745 | 830 | 963 | 1,553 | 1,490 | 1,466 | 900 | 1,053 | |
| 390 | 313 | 474 | 452 | 742 | 766 | 760 | 573 | |
| Trade Payables | 313 | 243 | 216 | 306 | 269 | 301 | 308 | 243 |
| 345 | 545 | 472 | 238 | 346 | 248 | 343 | 317 | |
| Total Liabilities | 1,817 | 1,957 | 2,152 | 2,585 | 2,882 | 2,816 | 2,347 | 2,225 |
| ASSETS | - | - | - | - | - | - | - | - |
| 1,057 | 1,182 | 1,362 | 1,349 | 1,325 | 1,333 | 1,259 | 1,185 | |
| Capital Work in Progress | 70 | 39 | 40 | 88 | 239 | 238 | 256 | 280 |
| 19 | 18 | 18 | 18 | 15 | 16 | 14 | 2 | |
| 188 | 214 | 280 | 295 | 576 | 558 | 360 | 318 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 351 | 327 | |
| Cash & Bank | 47 | 76 | 57 | 198 | 47 | 9 | 8 | 4 |
| 437 | 427 | 395 | 636 | 681 | 662 | 98 | 110 | |
| Total Assets | 1,817 | 1,957 | 2,152 | 2,585 | 2,882 | 2,816 | 2,347 | 2,225 |
| Total Debt | 633 | 538 | 707 | 607 | 1,025 | 1,001 | 999 | 776 |
| Net Working Capital | -124 | -1 | -52 | 273 | 184 | 95 | -447 | -209 |
| Contingent Liabilities | 8 | 6 | 5 | 6 | 3 | 4 | 60 | 60 |
| Book Value per Share | 312.02 | 332.19 | 368.74 | 442.25 | 423.90 | 417.24 | 259.94 | 271.53 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 633 | 538 | 707 | 607 | 1,025 | 1,001 | 999 | 776 |
| Net Working Capital | -124 | -1 | -52 | 273 | 184 | 95 | -447 | -209 |
| Contingent Liabilities | 8 | 6 | 5 | 6 | 3 | 4 | 60 | 60 |
| Book Value per Share | 312.02 | 332.19 | 368.74 | 442.25 | 423.90 | 417.24 | 259.94 | 271.53 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2018
- Equity Capital
- 25
- 745
- 390
- Trade Payables
- 313
- 345
- Total Liabilities
- 1,817
- 1,057
- Capital Work in Progress
- 70
- 19
- 188
- 0
- Cash & Bank
- 47
- 437
- Total Assets
- 1,817
- Total Debt
- 633
- Net Working Capital
- -124
- Contingent Liabilities
- 8
- Book Value per Share
- 312.02
- Face Value
- 10.00
- Total Debt
- 633
- Net Working Capital
- -124
- Contingent Liabilities
- 8
- Book Value per Share
- 312.02
- Face Value
- 10.00
Mar 2019
- Equity Capital
- 26
- 830
- 313
- Trade Payables
- 243
- 545
- Total Liabilities
- 1,957
- 1,182
- Capital Work in Progress
- 39
- 18
- 214
- 0
- Cash & Bank
- 76
- 427
- Total Assets
- 1,957
- Total Debt
- 538
- Net Working Capital
- -1
- Contingent Liabilities
- 6
- Book Value per Share
- 332.19
- Face Value
- 10.00
- Total Debt
- 538
- Net Working Capital
- -1
- Contingent Liabilities
- 6
- Book Value per Share
- 332.19
- Face Value
- 10.00
Mar 2020
- Equity Capital
- 27
- 963
- 474
- Trade Payables
- 216
- 472
- Total Liabilities
- 2,152
- 1,362
- Capital Work in Progress
- 40
- 18
- 280
- 0
- Cash & Bank
- 57
- 395
- Total Assets
- 2,152
- Total Debt
- 707
- Net Working Capital
- -52
- Contingent Liabilities
- 5
- Book Value per Share
- 368.74
- Face Value
- 10.00
- Total Debt
- 707
- Net Working Capital
- -52
- Contingent Liabilities
- 5
- Book Value per Share
- 368.74
- Face Value
- 10.00
Mar 2021
- Equity Capital
- 36
- 1,553
- 452
- Trade Payables
- 306
- 238
- Total Liabilities
- 2,585
- 1,349
- Capital Work in Progress
- 88
- 18
- 295
- 0
- Cash & Bank
- 198
- 636
- Total Assets
- 2,585
- Total Debt
- 607
- Net Working Capital
- 273
- Contingent Liabilities
- 6
- Book Value per Share
- 442.25
- Face Value
- 10.00
- Total Debt
- 607
- Net Working Capital
- 273
- Contingent Liabilities
- 6
- Book Value per Share
- 442.25
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 36
- 1,490
- 742
- Trade Payables
- 269
- 346
- Total Liabilities
- 2,882
- 1,325
- Capital Work in Progress
- 239
- 15
- 576
- 0
- Cash & Bank
- 47
- 681
- Total Assets
- 2,882
- Total Debt
- 1,025
- Net Working Capital
- 184
- Contingent Liabilities
- 3
- Book Value per Share
- 423.90
- Face Value
- 10.00
- Total Debt
- 1,025
- Net Working Capital
- 184
- Contingent Liabilities
- 3
- Book Value per Share
- 423.90
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 36
- 1,466
- 766
- Trade Payables
- 301
- 248
- Total Liabilities
- 2,816
- 1,333
- Capital Work in Progress
- 238
- 16
- 558
- 0
- Cash & Bank
- 9
- 662
- Total Assets
- 2,816
- Total Debt
- 1,001
- Net Working Capital
- 95
- Contingent Liabilities
- 4
- Book Value per Share
- 417.24
- Face Value
- 10.00
- Total Debt
- 1,001
- Net Working Capital
- 95
- Contingent Liabilities
- 4
- Book Value per Share
- 417.24
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 36
- 900
- 760
- Trade Payables
- 308
- 343
- Total Liabilities
- 2,347
- 1,259
- Capital Work in Progress
- 256
- 14
- 360
- 351
- Cash & Bank
- 8
- 98
- Total Assets
- 2,347
- Total Debt
- 999
- Net Working Capital
- -447
- Contingent Liabilities
- 60
- Book Value per Share
- 259.94
- Face Value
- 10.00
- Total Debt
- 999
- Net Working Capital
- -447
- Contingent Liabilities
- 60
- Book Value per Share
- 259.94
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 40
- 1,053
- 573
- Trade Payables
- 243
- 317
- Total Liabilities
- 2,225
- 1,185
- Capital Work in Progress
- 280
- 2
- 318
- 327
- Cash & Bank
- 4
- 110
- Total Assets
- 2,225
- Total Debt
- 776
- Net Working Capital
- -209
- Contingent Liabilities
- 60
- Book Value per Share
- 271.53
- Face Value
- 10.00
- Total Debt
- 776
- Net Working Capital
- -209
- Contingent Liabilities
- 60
- Book Value per Share
- 271.53
- Face Value
- 10.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| 50 | 166 | 242 | 154 | -242 | 156 | 111 | 213 | |
| Cash from Investing | -85 | -116 | -359 | -105 | -243 | -81 | -5 | -37 |
| Cash from Financing | 67 | -23 | 97 | 92 | 334 | -113 | -107 | -180 |
| 31 | 27 | -20 | 142 | -151 | -38 | -0 | -5 | |
| Free Cash Flow | 50 | -13 | -31 | 13 | -478 | 49 | 84 | 169 |
| OCF / Net Profit | 6.55 | 2.50 | 2.15 | 0.70 | 4.13 | -7.03 | -0.20 | -197.04 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | -459 | -362 | -162 |
| OCF / Net Profit | 6.55 | 2.50 | 2.15 | 0.70 | 4.13 | -7.03 | -0.20 | -197.04 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | -459 | -362 | -162 |
Mar 2018
- 50
- Cash from Investing
- -85
- Cash from Financing
- 67
- 31
- Free Cash Flow
- 50
- OCF / Net Profit
- 6.55
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 6.55
- Cumulative 5-Year FCF
- 0
Mar 2019
- 166
- Cash from Investing
- -116
- Cash from Financing
- -23
- 27
- Free Cash Flow
- -13
- OCF / Net Profit
- 2.50
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.50
- Cumulative 5-Year FCF
- 0
Mar 2020
- 242
- Cash from Investing
- -359
- Cash from Financing
- 97
- -20
- Free Cash Flow
- -31
- OCF / Net Profit
- 2.15
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.15
- Cumulative 5-Year FCF
- 0
Mar 2021
- 154
- Cash from Investing
- -105
- Cash from Financing
- 92
- 142
- Free Cash Flow
- 13
- OCF / Net Profit
- 0.70
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.70
- Cumulative 5-Year FCF
- 0
Mar 2022
- -242
- Cash from Investing
- -243
- Cash from Financing
- 334
- -151
- Free Cash Flow
- -478
- OCF / Net Profit
- 4.13
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 4.13
- Cumulative 5-Year FCF
- 0
Mar 2023
- 156
- Cash from Investing
- -81
- Cash from Financing
- -113
- -38
- Free Cash Flow
- 49
- OCF / Net Profit
- -7.03
- Cumulative 5-Year FCF
- -459
- OCF / Net Profit
- -7.03
- Cumulative 5-Year FCF
- -459
Mar 2024
- 111
- Cash from Investing
- -5
- Cash from Financing
- -107
- -0
- Free Cash Flow
- 84
- OCF / Net Profit
- -0.20
- Cumulative 5-Year FCF
- -362
- OCF / Net Profit
- -0.20
- Cumulative 5-Year FCF
- -362
Mar 2025
- 213
- Cash from Investing
- -37
- Cash from Financing
- -180
- -5
- Free Cash Flow
- 169
- OCF / Net Profit
- -197.04
- Cumulative 5-Year FCF
- -162
- OCF / Net Profit
- -197.04
- Cumulative 5-Year FCF
- -162
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - |
| EPS (₹) | 3.07 | 25.75 | 41.90 | 61.50 | -16.27 | -6.17 | -157.46 | -0.27 |
| Book Value (₹) | 312.02 | 332.19 | 368.74 | 442.25 | 423.90 | 417.24 | 259.94 | 271.53 |
| Dividend per Share (₹) | 0.00 | 5.00 | 2.00 | 7.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 15.47 | 53.34 | 70.77 | 84.46 | 13.68 | 22.71 | -118.75 | 24.39 |
| PROFITABILITY | - | - | - | - | - | - | - | - |
| Operating Margin % | 12.77% | 15.98% | 21.49% | 25.59% | 7.81% | 10.82% | -7.38% | 15.88% |
| Net Margin % | 1.45% | 4.78% | 8.51% | 13.67% | -4.62% | -1.54% | -43.98% | -0.08% |
| ROE % | 0.98% | 8.16% | 12.19% | 17.13% | -3.76% | -1.47% | -46.51% | -0.11% |
| ROCE % | 2.33% | 10.39% | 11.54% | 15.28% | -0.69% | 1.79% | -17.22% | 5.97% |
| 0.42% | 3.52% | 5.48% | 9.33% | -2.14% | -0.78% | -21.96% | -0.05% | |
| EFFICIENCY | - | - | - | - | - | - | - | - |
| Debtor Days | 185 | 73 | 72 | 81 | 140 | 130 | 126 | 96 |
| Inventory Days | 131 | 53 | 68 | 65 | 125 | 143 | 130 | 96 |
| Payable Days | 420 | 144 | 140 | 131 | 160 | 132 | 138 | 160 |
| -104 | -18 | 0 | 14 | 105 | 142 | 118 | 32 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.82x | 0.63x | 0.71x | 0.38x | 0.67x | 0.67x | 1.07x | 0.71x |
| Interest Coverage (x) | 1.30x | 1.83x | 2.44x | 3.62x | -0.22x | 0.50x | -3.61x | 0.99x |
| 0.83x | 1.00x | 0.93x | 1.35x | 1.17x | 1.09x | 0.64x | 0.78x | |
| GROWTH | - | - | - | - | - | - | - | - |
| Revenue Growth % | 0.00% | 166.17% | -4.68% | 22.33% | -21.56% | 13.83% | -10.73% | -0.40% |
| Operating Profit Growth % | 0.00% | 251.00% | 21.61% | 45.66% | -76.05% | 57.58% | -157.43% | 337.46% |
| Net Profit Growth % | 0.00% | 775.33% | 69.54% | 96.43% | -126.50% | 62.07% | -2452.32% | 99.81% |
| 0.00% | 738.09% | 0.00% | 0.00% | 0.00% | 0.00% | -2452.32% | 99.83% | |
| VALUATION | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 16.28x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| P/B (x) | 0.00x | 1.26x | 0.00x | 0.00x | 0.00x | 0.00x | 1.43x | 1.89x |
| Dividend Yield % | 0.00% | 1.19% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 6.60x | 0.00x | 0.00x | 0.00x | 0.00x | -26.00x | 13.31x |
Mar 2018
- EPS (₹)
- 3.07
- Book Value (₹)
- 312.02
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 15.47
- Operating Margin %
- 12.77%
- Net Margin %
- 1.45%
- ROE %
- 0.98%
- ROCE %
- 2.33%
- 0.42%
- Debtor Days
- 185
- Inventory Days
- 131
- Payable Days
- 420
- -104
- Debt to Equity (x)
- 0.82x
- Interest Coverage (x)
- 1.30x
- 0.83x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 25.75
- Book Value (₹)
- 332.19
- Dividend per Share (₹)
- 5.00
- Cash EPS (₹)
- 53.34
- Operating Margin %
- 15.98%
- Net Margin %
- 4.78%
- ROE %
- 8.16%
- ROCE %
- 10.39%
- 3.52%
- Debtor Days
- 73
- Inventory Days
- 53
- Payable Days
- 144
- -18
- Debt to Equity (x)
- 0.63x
- Interest Coverage (x)
- 1.83x
- 1.00x
- Revenue Growth %
- 166.17%
- Operating Profit Growth %
- 251.00%
- Net Profit Growth %
- 775.33%
- 738.09%
- P/E (x)
- 16.28x
- P/B (x)
- 1.26x
- Dividend Yield %
- 1.19%
- 6.60x
Mar 2020
- EPS (₹)
- 41.90
- Book Value (₹)
- 368.74
- Dividend per Share (₹)
- 2.00
- Cash EPS (₹)
- 70.77
- Operating Margin %
- 21.49%
- Net Margin %
- 8.51%
- ROE %
- 12.19%
- ROCE %
- 11.54%
- 5.48%
- Debtor Days
- 72
- Inventory Days
- 68
- Payable Days
- 140
- 0
- Debt to Equity (x)
- 0.71x
- Interest Coverage (x)
- 2.44x
- 0.93x
- Revenue Growth %
- -4.68%
- Operating Profit Growth %
- 21.61%
- Net Profit Growth %
- 69.54%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 61.50
- Book Value (₹)
- 442.25
- Dividend per Share (₹)
- 7.00
- Cash EPS (₹)
- 84.46
- Operating Margin %
- 25.59%
- Net Margin %
- 13.67%
- ROE %
- 17.13%
- ROCE %
- 15.28%
- 9.33%
- Debtor Days
- 81
- Inventory Days
- 65
- Payable Days
- 131
- 14
- Debt to Equity (x)
- 0.38x
- Interest Coverage (x)
- 3.62x
- 1.35x
- Revenue Growth %
- 22.33%
- Operating Profit Growth %
- 45.66%
- Net Profit Growth %
- 96.43%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- -16.27
- Book Value (₹)
- 423.90
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 13.68
- Operating Margin %
- 7.81%
- Net Margin %
- -4.62%
- ROE %
- -3.76%
- ROCE %
- -0.69%
- -2.14%
- Debtor Days
- 140
- Inventory Days
- 125
- Payable Days
- 160
- 105
- Debt to Equity (x)
- 0.67x
- Interest Coverage (x)
- -0.22x
- 1.17x
- Revenue Growth %
- -21.56%
- Operating Profit Growth %
- -76.05%
- Net Profit Growth %
- -126.50%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- -6.17
- Book Value (₹)
- 417.24
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 22.71
- Operating Margin %
- 10.82%
- Net Margin %
- -1.54%
- ROE %
- -1.47%
- ROCE %
- 1.79%
- -0.78%
- Debtor Days
- 130
- Inventory Days
- 143
- Payable Days
- 132
- 142
- Debt to Equity (x)
- 0.67x
- Interest Coverage (x)
- 0.50x
- 1.09x
- Revenue Growth %
- 13.83%
- Operating Profit Growth %
- 57.58%
- Net Profit Growth %
- 62.07%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- -157.46
- Book Value (₹)
- 259.94
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -118.75
- Operating Margin %
- -7.38%
- Net Margin %
- -43.98%
- ROE %
- -46.51%
- ROCE %
- -17.22%
- -21.96%
- Debtor Days
- 126
- Inventory Days
- 130
- Payable Days
- 138
- 118
- Debt to Equity (x)
- 1.07x
- Interest Coverage (x)
- -3.61x
- 0.64x
- Revenue Growth %
- -10.73%
- Operating Profit Growth %
- -157.43%
- Net Profit Growth %
- -2452.32%
- -2452.32%
- P/E (x)
- 0.00x
- P/B (x)
- 1.43x
- Dividend Yield %
- 0.00%
- -26.00x
Mar 2025
- EPS (₹)
- -0.27
- Book Value (₹)
- 271.53
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 24.39
- Operating Margin %
- 15.88%
- Net Margin %
- -0.08%
- ROE %
- -0.11%
- ROCE %
- 5.97%
- -0.05%
- Debtor Days
- 96
- Inventory Days
- 96
- Payable Days
- 160
- 32
- Debt to Equity (x)
- 0.71x
- Interest Coverage (x)
- 0.99x
- 0.78x
- Revenue Growth %
- -0.40%
- Operating Profit Growth %
- 337.46%
- Net Profit Growth %
- 99.81%
- 99.83%
- P/E (x)
- 0.00x
- P/B (x)
- 1.89x
- Dividend Yield %
- 0.00%
- 13.31x
Documents
Announcements
- Updates
2026-08-19 - Solara Active Pharma Sciences Limited has informed the Exchange regarding Conversion of partly paid-up Rights Equity Shares into fully paid-up equity shares in Conversion of partly paid-up Rights Equity Shares into fully paid-up equity shares in relation to the rights issue by the Company, upon receipt of the Call Monies, as applicable.
- ESOP/ESOS/ESPS
2026-08-18 - Solara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 2250 equity shares pursuant to exercise of ESOP options.
Annual Reports
Credit Ratings
- Credit Rating
2026-06-23 - Solara Active Pharma Sciences Limited has informed the Exchange about Credit Rating
Concalls
Jul 2026
May 2026
Feb 2026